Manning & Napier Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$162K Buy
448
+267
+148% +$91.4K ﹤0.01% 340
2026
Q1
$63.2K Buy
181
+84
+87% +$29.9K ﹤0.01% 354
2025
Q4
$31.9K Buy
97
+32
+49% +$10.2K ﹤0.01% 347
2025
Q3
$18.3K Buy
+65
New +$18.9K ﹤0.01% 377
2017
Q3
$21.4M Sell
114,745
-425
-0.4% -$75.3K 0.18% 87
2017
Q2
$19.8M Buy
115,170
+40,789
+55% +$6.63M 0.17% 85
2017
Q1
$12.2M Buy
74,381
+3,378
+5% +$561K 0.09% 93
2016
Q4
$10.4M Buy
71,003
+2,508
+4% +$377K 0.07% 118
2016
Q3
$11.4M Sell
68,495
-1,263
-2% -$214K 0.07% 109
2016
Q2
$10.6M Buy
+69,758
New +$10.8M 0.06% 115
2013
Q4
Sell
-5,241
Closed -$586K 335
2013
Q3
$586K Sell
5,241
-123,656
-96% -$13.4M ﹤0.01% 313
2013
Q2
$12.7M Buy
+128,897
New +$13.4M 0.07% 134

Other funds holding AMGN

Manning & Napier Advisors's AMGN Position: Q2 2026 in Review

Manning & Napier Advisors increased its Amgen (AMGN) stake by 148% in Q2 2026, buying an estimated $91.4K and bringing the position to 448 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #340.

Manning & Napier Advisors first reported a position in AMGN in Q2 2013 and has held it in 12 quarters since. The position peaked at $21.4M in Q3 2017. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Manning & Napier Advisors held 448 shares of Amgen worth $162K as of Q2 2026.
  • Manning & Napier Advisors bought 267 Amgen shares in Q2 2026, an estimated $91.4K.
  • Amgen made up ﹤0.01% of Manning & Napier Advisors's portfolio in Q2 2026, its #340 holding.
  • Manning & Napier Advisors first reported a position in Amgen in Q2 2013 and has held it in 12 quarters since.
  • Manning & Napier Advisors's Amgen position peaked at $21.4M in Q3 2017.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.